WHITEHAWK THERAPEUTICS, INC. Increase (Decrease) in Other Current Assets
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Increase (Decrease) in Other Current Assets of -$1.03 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2021-08-11
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2021-06-30 was -$1.16M.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2021-03-31 was $129.74K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2020-12-31 was -$221.54K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2020-09-30 was $1.58M, a 158.48% increase year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2020 was $869.13K, a 629.72% increase from fiscal 2019.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2019 was $119.10K, a 59.41% decline from fiscal 2018.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2018 was $293.46K, a 169.17% increase from fiscal 2017.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2017 was $109.03K.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$1.03M 10-Q · filed 2021-08-11 | -$1.25M derived: sum of 3 quarters · filed 2021-08-11 | $335.38K derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | $129.74K 10-Q · filed 2021-05-17 | -$91.80K derived: sum of 2 quarters · filed 2021-05-17 | $1.49M derived: sum of 3 quarters · filed 2021-05-17 | $1.17M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-12-31 | -$221.54K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.36M derived: sum of 2 quarters · filed 2021-03-11 | $1.04M derived: sum of 3 quarters · filed 2021-08-11 | $869.13K 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $1.26M derived: sum of 2 quarters · filed 2021-08-11 | $1.09M 10-Q · filed 2020-11-10 | $948.96K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-06-30 | -$324.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$491.70K 10-Q · filed 2021-08-11 | -$633.41K derived: sum of 3 quarters · filed 2021-08-11 | -$21.22K derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | -$167.29K 10-Q · filed 2021-05-17 | -$308.99K derived: sum of 2 quarters · filed 2021-05-17 | $303.19K derived: sum of 3 quarters · filed 2021-05-17 | $31.32K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$141.71K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $470.48K derived: sum of 2 quarters · filed 2021-03-11 | $198.61K derived: sum of 3 quarters · filed 2021-03-11 | $119.10K 10-K · filed 2021-03-11 |
| 2019-09-30 | $612.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $340.32K derived: sum of 2 quarters · filed 2020-11-10 | $260.81K 10-Q · filed 2020-11-10 | -$18.60K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | -$271.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$351.38K 10-Q · filed 2020-08-12 | -$630.79K derived: sum of 3 quarters · filed 2020-08-12 | $50.84K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$79.51K 10-Q · filed 2020-05-07 | -$358.92K derived: sum of 2 quarters · filed 2020-05-07 | $322.71K derived: sum of 3 quarters · filed 2020-05-07 | $138.59K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$279.41K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $402.22K derived: sum of 2 quarters · filed 2020-03-16 | $218.09K derived: sum of 3 quarters · filed 2020-03-16 | $293.46K 10-K · filed 2020-03-16 |
| 2018-09-30 | $681.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $497.50K derived: sum of 2 quarters · filed 2019-11-07 | $572.87K 10-Q · filed 2019-11-07 | $25.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$184.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$108.76K 10-Q · filed 2019-08-08 | -$656.63K derived: sum of 3 quarters · filed 2019-08-08 | -$221.95K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $75.36K 10-Q · filed 2019-05-09 | -$472.50K derived: sum of 2 quarters · filed 2019-05-09 | -$37.83K derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | -$547.87K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$113.19K derived: sum of 2 quarters · filed 2019-03-07 | $109.03K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $434.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $656.90K 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $222.22K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |